Skip to content
All news
ProductLaunch

IBM Jumps 15.8% on $2B Quantum Chip Foundry Partnership

IBM (NYSE: IBM) and the U.S. Department of Commerce announced a Letter of Intent to create Anderon, America's first pure-play quantum chip foundry in Albany, New York, backed by $2 billion in total investment. IBM shares rose 15.8% on the news.

May 23, 2026
2 min read
Source: Simply Wall St.
Share:

Key Numbers

investment
$2 billion
CHIPS incentives
$1 billion
IBM cash
$1 billion
stock gain
15.8%

IBM (NYSE: IBM) and the U.S. Department of Commerce announced a Letter of Intent to establish Anderon, America's first pure-play quantum chip foundry, in Albany, New York. The total investment is $2 billion, comprising $1 billion in CHIPS Act incentives and $1 billion in cash, intellectual property, and staff from IBM. The stock surged 15.8% following the announcement.

The Product

Anderon is a dedicated 300-millimeter quantum wafer facility designed to supply multiple customers with quantum chips. It aims to solidify the U.S. quantum ecosystem and reduce supply chain dependencies.

Pricing and Availability

Pricing details and a commercial production timeline have not been disclosed. The facility is expected to become operational within the next few years.

Competition

IBM faces competition from Google, Microsoft, and startups like Rigetti Computing and IonQ in the quantum computing space. However, the government partnership gives IBM a significant competitive edge.

Potential Impact on IBM

The project is expected to strengthen IBM's leadership in quantum computing and generate long-term revenue from chip sales and licensing. Government backing mitigates financial risks.

Frequently Asked Questions

Anderon is America's first pure-play quantum chip foundry, established through a partnership between IBM and the U.S. Department of Commerce in Albany, New York.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.